Team:UT Dallas

From 2011.igem.org

(Difference between revisions)
Line 404: Line 404:
       <ul>
       <ul>
-
         <li class = "active"><a href="https://2011.igem.org/Team:UT_Dallas"><font size="3" face="verdana">Home</a></font></li>
+
         <li class = "active"><a href="#"><font size="3" face="verdana">Home</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Project</a></font></li>
         <li><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Project</a></font></li>
Line 477: Line 477:
           <div class="clr"></div>
           <div class="clr"></div>
           <ul class="sb_menu">
           <ul class="sb_menu">
-
             <li class = "active"><a href="https://2011.igem.org/Team:UT_Dallas"><font size="4" face="verdana">Home</a></font></li>
+
             <li class = "active"><a href="#"><font size="4" face="verdana">Home</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Team"><font size="3" face="verdana">Team</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Project</a></font></li>
             <li><a href="https://2011.igem.org/Team:UT_Dallas/Project"><font size="3" face="verdana">Project</a></font></li>

Revision as of 20:50, 15 August 2011

biz solution

UTDallas iGem 2011

Tissue damage characterizes a range of medical conditions that can be particularly difficult to manage without restrictively risky or expensive intervention. The human body hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for synthetic bacterial systems. We aim to construct a probiotic solution that successfully interfaces with the immune system to facilitate localized tissue repair.

Read more

Safety Proposal



















Image Gallery

Notebook

Learn more...